MicroRNA-183-5p negatively regulates interleukin-8 expression in cervical cancer cells.

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Interleukin-8 (IL-8) and microRNA-183-5p (hsa-miR-183-5p) are implicated in cervical cancer development.
• The regulatory relationship between IL-8 and hsa-miR-183-5p in this context remains unexplored.

Purpose of the Study:

• To investigate whether phorbol 12-myristate 13-acetate (PMA)-induced IL-8 expression is regulated by hsa-miR-183-5p in cervical cancer cells.
• To elucidate the direct interaction between hsa-miR-183-5p and IL-8 mRNA.

Main Methods:

• Bioinformatic prediction of hsa-miR-183-5p binding to the IL-8 mRNA 3'UTR.
• Quantification of hsa-miR-183-5p and IL-8 mRNA/protein levels in CaSKi cervical cancer cells using Taqman assays and ELISA.
• Validation through luciferase reporter assays and transfection with pre-miR-183-5p and anti-miR-183-5p.

Main Results:

• hsa-miR-183-5p was predicted to bind to the IL-8 mRNA 3'UTR.
• PMA-induced IL-8 expression showed an inverse correlation with hsa-miR-183-5p levels.
• hsa-miR-183-5p significantly inhibited IL-8 expression at both mRNA and protein levels, confirmed by reporter assays and transfection studies.

Conclusions:

• This study provides the first evidence that hsa-miR-183-5p directly regulates IL-8 expression in cervical cancer.
• Both IL-8 and hsa-miR-183-5p represent promising therapeutic targets for cervical cancer intervention.